Mathieu Joseph François Crupi

8PUBLICATIONS
40CO-AUTHORS
Molecular targetsAgricultural molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.

Zaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani

|Jun 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.

Jonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer

|May 27, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.

Nikolas T Martin, Mathieu J F Crupi, Zaid Taha

|Jan 21, 2023
Extracellular Vesicles and Viruses: Two Intertwined Entities.

Coline Moulin, Mathieu J F Crupi, Carolina S Ilkow

|Apr 03, 2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion.

Taha Azad, Reza Rezaei, Ragunath Singaravelu

|Mar 06, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.

Emily E F Brown, Reza Rezaei, Taylor R Jamieson

Pageof 2

Frequent Collaborators

3 joint publications

Zaid Taha

3 joint publications

Taha Azad

3 joint publications

Reza Rezaei

2 joint publications

Stephen Boulton